Hjem › Sklerodermi › Pennsylvania › Pittsburgh
Sklerodermi kliniske forsøg i Pittsburgh, PA
5 studier for Sklerodermi søger deltagere på steder i og omkring Pittsburgh (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- UPMC Hillman Cancer Center, Pittsburgh
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
- GSK Investigational Site, Pittsburgh
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RekruttererFase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Intralesional Injection of STS in Treatment of Calcinosis
RekruttererFase 2
- UPMC Arthritis and Autoimmunity Center, Pittsburgh
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Rekrutterer
- University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
Sklerodermi forsøg i andre byer
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Chicago, IL10 studier
- Houston, TX9 studier
- Boston, MA7 studier
- Durham, NC7 studier
- Los Angeles, CA7 studier
- New Orleans, LA6 studier
- Baltimore, MD6 studier
- Philadelphia, PA6 studier
- Dallas, TX5 studier
- Plantation, FL4 studier
Andre studier i Pittsburgh
- Ikke-småcellet lungecancer48 studier
- Kræft (alle typer)41 studier
- Brystkræft39 studier
- Colorektal kræft32 studier
- Metastatisk cancer31 studier
- Melanom31 studier
- Ægstockræft30 studier
- Livmoderslimhindekræft23 studier
- Lungecancer23 studier
- Prostatakræft23 studier
- Slagtilfælde22 studier
- Pladecellekræft i hoved og hals22 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.